NCT03959800 Molecular Basis of Pediatric Liver Cancer
| NCT ID | NCT03959800 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Childhood Liver Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2015-06-22 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,600 participants in total. It began in 2015-06-22 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.
Eligibility Criteria
Inclusion Criteria: * Prior or current treatment for a childhood liver tumor, malignant or benign, at age \<21 years. * Biological parents and siblings of eligible children. Exclusion Criteria: * No prior or current treatment for a childhood liver tumor. * Non-biological parents, legal guardians, or non-biological siblings of eligible children.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03959800 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 99 Years, studying Childhood Liver Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03959800 currently recruiting?
Yes, NCT03959800 is actively recruiting participants. Contact the research team at Morgan.Paul2@upmc.edu for enrollment information.
Where is the NCT03959800 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT03959800 clinical trial?
NCT03959800 is sponsored by University of Pittsburgh. The trial plans to enroll 1,600 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.